Ardsley-based Acorda Therapeutics Inc. has filed a lawsuit in federal court in Delaware alleging Mylan Inc. infringed on its patents for the multiple sclerosis drug Ampyra.
Mylan, based in Canonsburg, Pa., notified Acorda by letter on July 9 that it had filed an Abbreviated New Drug Application seeking approval from the Food and Drug Administration to sell generic tablets of Ampyra. In the complaint filed Wednesday, Acorda alleged the filing of the application constitutes infringement of five patents either held or licensed to Acorda.
Acorda”™s complaint seeks declarations that Mylan infringed on Acorda”™s patents, an injunction against Mylan”™s production, distribution, or sale of a generic Ampyra tablet prior to the expiration of Acorda”™s patents, as well as attorney fees, costs and expenses.
